References
- Kupfer C. Bowman Lecture. The conquest of cataract: a global challenge. Trans. Ophthal. Soc. UK104, 1–10 (1984).
- World Health Organization. The World Health Report: Life in the 21st Century – A Vision For All. WHO, Geneva, Switzerland, 47 (1998).
- Foster A. Cataract and “Vision 2020 – the right to sight” initiative. Br. J. Ophthalmol.85, 635–637 (2001).
- Farcia-Arumi J, Fonollosa A, Sarrarols L et al. Topical anesthesia: possible risk factor for endophthalmitis after cataract extraction. J. Cataract. Refract. Surg.33, 989–992 (2007).
- Ellis MF. Topical anesthesia:a risk factor for post-cataract extraction endophthalmitis? Clin. Exp. Ophthalmol.31, 125–128 (2003).
- ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors. J. Cataract Refract. Surg.33, 978–988 (2007).
- Monica ML, Long DA. Nine-year safety with self-sealing corneal tunnel incision in clear cornea cataract surgery. Ophthalmology112, 985–986 (2005).
- Bardocci A, Lofoco G, Perdicaro S, Ciucci F, Manna L. Lidocaine 2% gel versus lidocaine 4% unpreserved drops for topical anesthesia in cataract surgery: a randomized controlled trial. Ophthalmology110, 144–149 (2003).
- Koch PS. Efficacy of lidocaine 2% jelly as a topical agent in cataract surgery. J. Cataract. Refract. Surg.25(5), 632–634 (1999).
- Barequet IS, Soriano ES, Green WR, O’Brien TP. Provision of anesthesia with single application of lidocaine 2% gel. J. Cataract. Refract. Surg.25(5), 626–631 (1999).
- Amiel H, Koch PS. A comparative clinical trial of tetracaine hydrochloride 0.5% versus lidocaine 2% jelly as a topical anesthetic in cataract surgery. J. Cataract. Refract. Surg.33(1), 98–100 (2007).
- Gilman AG, Rall TW, Nies AS, Taylor P (Eds). Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 8th Edn.Pergamon Press, NY, USA, 312–318 (1990).
- Havener WH. Ocular Pharmacology, 5th Edn. Mosby, MO, USA, 75–78 (1983).
- Cydulka RK, Betzelos S. Seizures following the use of proparacaine hydrochloride eye drops. J. Emerg. Med.8, 131–133 (1990).
- Pontocaine hydrochloride ophthalmic solution, Package insert. Sanofi Aventis, Bridgewater, NJ, USA.
- TetraVisc-tetracaine hydrochloride ophthalmic solution, Package insert. Cynacon/Ocusoft, Richmond, TX, USA.
- Proparacaine hydrochloride ophthalmic solution, Package insert. Bauch & Lomb Rochester, NY, USA.
- Brent MH, Slomovic AR, Easterbrook M. Keratitis associated with the use of proparacaine hydrochloride. Can. Med. Assoc. J.186, 380–381 (1987).
- Eke T, Thompson JR. Serious complications of local anaesthesia for cataract surgery: a 1 year national survey in the United Kingdom. Br. J. Ophthalmol.91(4), 470–475 (2007).